ABCL
AbCellera Biologics Inc.Company with tickers: ABCL
CIK
1703057
CUSIP
00288U106
Shares Outstanding
305,375,393
Website
https://www.abcellera.com
Investor Relations
https://investors.abcellera.com/overview/default.aspx
13F Activity (30d)
3 filings
2 filers
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding ABCL
19 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| SMALLCAP World Fund Inc | — | 13,361,096 | $46,630,225 | 0.06% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 1,732,022 | $6,044,757 | 0.07% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | — | 564,888 | $1,971,459 | 0.01% | Long | 2026-03-31 | |
| BlackRock Advantage Small Cap Core Fund | — | 340,523 | $1,229,288 | 0.03% | Long | 2026-02-27 | |
| Driehaus Micro Cap Growth Fund | — | 249,240 | $869,848 | 0.19% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 176,961 | $638,829 | 0.00% | Long | 2026-02-28 | |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | — | 164,325 | $573,494 | 0.07% | Long | 2026-03-31 | |
| Fidelity Nasdaq Composite Index ETF | — | 135,099 | $487,707 | 0.01% | Long | 2026-02-28 | |
| Adara Smaller Companies Fund | — | 120,162 | $433,785 | 0.06% | Long | 2026-02-28 | |
| Small Cap Value Fund | — | 123,712 | $431,755 | 0.07% | Long | 2026-03-31 | |
| Virtus Biotech Clinical Trials Etf | — | 76,245 | $316,417 | 0.85% | Long | 2026-04-30 | |
| Avantis U.S. Equity ETF | — | 64,811 | $233,968 | 0.00% | Long | 2026-02-28 | |
| Blackstone Alternative Multi-Strategy Fund | — | 66,600 | $232,434 | 0.01% | Long | 2026-03-31 | |
| Destinations Small-Mid Cap Equity Fund | — | 44,214 | $159,613 | 0.02% | Long | 2026-02-28 | |
| Avantis U.S. Small Cap Equity ETF | — | 39,804 | $143,692 | 0.01% | Long | 2026-02-28 | |
| Diversified Equity Master Portfolio | — | 17,689 | $61,735 | 0.00% | Long | 2026-03-31 | |
| Invesco Nasdaq Biotechnology ETF | — | 16,724 | $60,374 | 0.08% | Long | 2026-02-28 | |
| ProShares Ultra Nasdaq Biotechnology | — | 13,822 | $49,897 | 0.05% | Long | 2026-02-28 | |
| Avantis U.S. Equity Fund | — | 9,145 | $33,013 | 0.00% | Long | 2026-02-28 |
Showing 1–19 of 19 positions